Johnson & Johnson Slashes Outlook, Races To Develop Coronavirus Vaccine

Video Credit: CBS 3 Philly
Published on April 15, 2020 - Duration: 00:37s

Johnson & Johnson Slashes Outlook, Races To Develop Coronavirus Vaccine

The world’s biggest health products maker on Tuesday said it now expects 2020 revenue of $77.5 billion to $80.5 billion.

Katie Johnston reports.


You are here

You might like